Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

QLI

Qilian (QLI)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:QLI
DataOraFonteTitoloSimboloCompagnia
18/06/202414:30PR Newswire (US)Qilian International Holding Group Limited Announces 1 for 5 Reverse Share SplitNASDAQ:QLIQilian International Holding Group Ltd
06/06/202422:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:QLIQilian International Holding Group Ltd
17/05/202416:00PR Newswire (US)Qilian International plans to adjust industrial investmentNASDAQ:QLIQilian International Holding Group Ltd
17/05/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:QLIQilian International Holding Group Ltd
08/05/202423:01Edgar (US Regulatory)Form F-3/A - Registration statement by foreign private issuers: [Amend]NASDAQ:QLIQilian International Holding Group Ltd
15/02/202422:27Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:QLIQilian International Holding Group Ltd
01/02/202422:15Edgar (US Regulatory)Form NT 20-F - Notification of inability to timely file Form 20-FNASDAQ:QLIQilian International Holding Group Ltd
12/01/202413:30PR Newswire (US)Qilian International Holding Group Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price RuleNASDAQ:QLIQilian International Holding Group Ltd
17/07/202316:30PR Newswire (US)Qilian International Holding Group Ltd Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyNASDAQ:QLIQilian International Holding Group Ltd
26/04/202323:11Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:QLIQilian International Holding Group Ltd
26/04/202323:00PR Newswire (US)Qilian Received a Letter from Nasdaq Related to Regain ComplianceNASDAQ:QLIQilian International Holding Group Ltd
19/04/202323:29Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:QLIQilian International Holding Group Ltd
23/02/202322:30PR Newswire (US)Qilian Received Notification of Deficiency from Nasdaq Related to not timely Filing of Annual Report Form 20-FNASDAQ:QLIQilian International Holding Group Ltd
16/02/202322:30PR Newswire (US)Qilian International Holding Group Ltd Declares Special Cash Dividends to ShareholdersNASDAQ:QLIQilian International Holding Group Ltd
31/01/202323:01Edgar (US Regulatory)Notification That Form 20-f Will Be Submitted Late (nt 20-f)NASDAQ:QLIQilian International Holding Group Ltd
13/10/202222:47Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)NASDAQ:QLIQilian International Holding Group Ltd
30/09/202222:30PR Newswire (US)Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2022NASDAQ:QLIQilian International Holding Group Ltd
11/02/202223:05PR Newswire (US)Qilian International Holding Group Limited Reports Fiscal Year 2021 Financial ResultsNASDAQ:QLIQilian International Holding Group Ltd
19/01/202213:30PR Newswire (US)Qilian International Holding Group Limited Receives Approval for the Sale of its Newly Developed Nitrofurantoin Enteric-coated TabletsNASDAQ:QLIQilian International Holding Group Ltd
11/01/202213:00PR Newswire (US)Qilian International Holding Group Limited Releases 2022 Chairman LetterNASDAQ:QLIQilian International Holding Group Ltd
23/11/202113:00PR Newswire (US)Qilian International Holding Group Limited Announces Inclusion of Gan Di Xin® and Qilian Shan® Oxytetracycline into List for Development of Leading Enterprises with Large Varieties and Brands of Pharmaceuticals of Gansu ProvinceNASDAQ:QLIQilian International Holding Group Ltd
15/11/202113:00PR Newswire (US)Qilian International Holding Group Limited Announces Initiation of Development of New Drug for Gastric Cancer PreventionNASDAQ:QLIQilian International Holding Group Ltd
01/11/202113:00PR Newswire (US)Qilian International Holding Group Limited Donates Pharmaceutical Products Gan Di Xin® Worth RMB500,000 and Other Materials to Help Fight Local COVID-19 EpidemicNASDAQ:QLIQilian International Holding Group Ltd
26/10/202114:00PR Newswire (US)Qilian International Holding Group Limited Completes Phase One of Its Expansion of New Organic Fertilizer Production Facility and Puts It into ProductionNASDAQ:QLIQilian International Holding Group Ltd
13/10/202114:00PR Newswire (US)Qilian International Holding Group Limited Received Approval for Oxytetracycline API Export to EgyptNASDAQ:QLIQilian International Holding Group Ltd
16/09/202122:10GlobeNewswire Inc.Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2021NASDAQ:QLIQilian International Holding Group Ltd
05/08/202122:30GlobeNewswire Inc.Qilian International Holding Group Limited Signs Agreement with District Government, Settling the Project in Local High-tech ZoneNASDAQ:QLIQilian International Holding Group Ltd
09/07/202114:00GlobeNewswire Inc.Qilian International Holding Group Limited Enters into Investment Agreement for Pig By-product Processing Project in Chongqin...NASDAQ:QLIQilian International Holding Group Ltd
05/05/202114:00GlobeNewswire Inc.Qilian International Holding Group Limited Enters into Exclusive Agency Agreement with Kangzhiyuan to Boost Sales of Gan Di X...NASDAQ:QLIQilian International Holding Group Ltd
13/04/202113:00GlobeNewswire Inc.Qilian International Holding Group Limited Announces Inclusion of 16 Products into China's National Reimbursement Drugs ListNASDAQ:QLIQilian International Holding Group Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:QLI

La tua Cronologia

Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network